Industry

Spectricept HLD Body MIST is a proven skin-safe sporicidal disinfectant wash, effective against a broad spectrum of pathogens, including Clostridioides difficile (C. difficile) spores, the bacteria that causes potentially life-threatening gastrointestinal infections common in healthcare settings After two minutes of contact time, Spectricept eradicates all C. difficile spores on the skin’s surface, making it more … [Read more…]

Updated LuMIERE Phase 1 data demonstrated a manageable safety profile with some preliminary evidence of anti-tumor activity Eleven patients treated to date with 177Lu-FAP-2286 up to 7.4 GBq/dose No serious adverse events, treatment discontinuations, or deaths related to 177Lu-FAP-2286 observed Confirmed partial response (PR) in one patient who completed the maximum six administrations of 177Lu-FAP-2286 … [Read more…]

Expanded capabilities support development and production of novel functional lipid excipients and nanoparticle formulation Addition of late stage clinical and commercial-scale production is also planned Company to present on shielding lipid novel excipients for lipid nanoparticle (LNP) formulations at Lipid Nanoparticles Development Summit on October 20th VALENCIA, Spain & BOSTON–(BUSINESS WIRE)–Polypeptide Therapeutic Solutions (PTS), a … [Read more…]

MELBOURNE, Australia–(BUSINESS WIRE)–#Connect2MyDoctor–Connect2MyDoctor, the comprehensive virtual care platform which has firmly established itself as a leading online healthcare service provider in Asia and Middle East, has signed a Memorandum of Understanding (MoU) with the University of Sharjah to exchange scientific and medical expertise. The institutions have agreed to collaborate on research activities that will extend … [Read more…]

$16.5 million to recover past royalties and interest Cessation of double-digit royalty/supply payments PEARL RIVER, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that a three-judge arbitration panel has issued a final decision in a dispute with Alkermes PLC (Nasdaq: ALKS) regarding licensing royalties relating to AMPYRA (dalfampridine). Acorda was awarded $15 million plus prejudgment … [Read more…]

Omni Legend is an innovative, breakthrough technology built from the ground up to harness the power of an advanced digital detector capable of producing high-resolution images and exceptional image quality with enhanced clinical efficiency The Omni PET/CT platform accommodates patients across more care areas and offers a scalable design to easily enable future-ready capabilities and … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced that management will participate in a fireside chat and one-on-one meetings at the H.C. Wainwright 6th Annual NASH Investor Conference taking place virtually on October 17th, 2022. Details … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Remote Patient Monitoring (RPM) Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End user (Providers, Hospitals, Clinics, Homecare, Patients, Payers) – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global remote patient monitoring market is projected to reach USD 175.2 Billion by 2027 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “RNA Analysis / Transcriptomics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global RNA Analysis / Transcriptomics Market to Reach $11.8 Billion by 2027 In the changed post COVID-19 business landscape, the global market for RNA Analysis / Transcriptomics estimated at US$4.7 Billion in the year 2020, is … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Synthetic Biology – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Synthetic Biology Market to Reach $36 Billion by 2027 In the changed post COVID-19 business landscape, the global market for Synthetic Biology estimated at US$6.4 Billion in the year 2020, is projected to reach a revised size … [Read more…]